Report cover image

Ellume Ltd - Product Pipeline Analysis, 2023 Update

Publisher GlobalData
Published Apr 08, 2024
Length 35 Pages
SKU # GBDT18719596

Description

Summary


Ellume Ltd (Ellume) is a health technology company. The company operates in quantum dot based diagnostics to enable real-time detection of common conditions including influenza, strep throat and chlamydia. It develops ellume lab, a versatile and convenient diagnostic device that complements a doctor’s decision-making and allows for accurate and real-time near-patient testing in a doctor’s office. Ellume also provides quantum dot fluorescent nanoparticles, fluorescent immunoassay reader and technology integration services. It developd technology such as patended platform technology, digital connectivity and real-time reporting and others.. The company offers medical diagnostic products to healthcare markets. Ellume is headquartered in East Brisbane, Queensland, Australia.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Ellume Ltd
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note:Some sections may be missing if data is unavailable for the company

Table of Contents

35 Pages
Ellume Ltd Company Overview
Ellume Ltd Company Snapshot
Ellume Ltd Pipeline Products and Ongoing Clinical Trials Overview
Ellume Ltd – Pipeline Analysis Overview
Ellume Ltd - Key Facts
Ellume Ltd - Major Products and Services
Ellume Ltd Pipeline Products by Development Stage
Ellume Ltd Pipeline Products Overview
Ellume Respirio Flu Test
Ellume Respirio Flu Test Product Overview
ellume.lab - Influenza A+B / RSV
ellume.lab - Influenza A+B / RSV Product Overview
ellume·lab
ellume·lab Product Overview
ESP-Based Diagnostic Test - Chlamydia
ESP-Based Diagnostic Test - Chlamydia Product Overview
ESP-Based Diagnostic Test - Gonorrhoea
ESP-Based Diagnostic Test - Gonorrhoea Product Overview
ESP-Based Diagnostic Test - Group A Streptococci
ESP-Based Diagnostic Test - Group A Streptococci Product Overview
ESP-Based Diagnostic Test - Malaria
ESP-Based Diagnostic Test - Malaria Product Overview
ESP-Based Diagnostic Test - Pregnancy
ESP-Based Diagnostic Test - Pregnancy Product Overview
Point of Care Flu-COVID Combination Diagnostic Test
Point of Care Flu-COVID Combination Diagnostic Test Product Overview
Smart Phone Enabled Device
Smart Phone Enabled Device Product Overview
Ellume Ltd - Key Competitors
Ellume Ltd - Key Employees
Ellume Ltd - Locations And Subsidiaries
Head Office
Recent Developments
Ellume Ltd, Recent Developments
Jul 14, 2022: Ellume COVID-19 Home Test now available through covid.gov/tests for blind and low-vision people
Dec 13, 2021: Ellume COVID-19 Home Test to allow users to send results directly to healthcare providers
Dec 03, 2021: Emerging omicron variant reinforces the role of rapid antigen testing
Nov 10, 2021: Ellume recalls COVID-19 home test for potential false positive SARS-CoV-2 test results
Oct 08, 2021: Coronavirus (COVID-19) update: October 8, 2021
Oct 06, 2021: Ellume recalls 200,000 Covid-19 test kits over false positives
Oct 05, 2021: Potential for false positive results with certain lots of Ellume COVID-19 home tests due to a manufacturing issue: FDA safety communication
May 10, 2021: Ellume establishes flagship U.S. manufacturing facility in Maryland
Mar 10, 2021: Ellume and Cambridge Consultants collaborate on Core Technology behind Ellume’s Rapid Antigen COVID-19 Test
Feb 01, 2021: Ellume announces $231.8 million agreement with the U.S. government
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Table 1: Ellume Ltd Pipeline Products and Ongoing Clinical Trials Overview
Table 2: Ellume Ltd Pipeline Products by Equipment Type
Table 3: Ellume Ltd Pipeline Products by Indication
Table 4: Ellume Ltd, Key Facts
Table 5: Ellume Ltd, Major Products and Services
Table 6: Ellume Ltd Number of Pipeline Products by Development Stage
Table 7: Ellume Ltd Pipeline Products Summary by Development Stage
Table 8: Ellume Respirio Flu Test - Product Status
Table 9: Ellume Respirio Flu Test - Product Description
Table 10: ellume.lab - Influenza A+B / RSV - Product Status
Table 11: ellume.lab - Influenza A+B / RSV - Product Description
Table 12: ellume·lab - Product Status
Table 13: ellume·lab - Product Description
Table 14: ESP-Based Diagnostic Test - Chlamydia - Product Status
Table 15: ESP-Based Diagnostic Test - Chlamydia - Product Description
Table 16: ESP-Based Diagnostic Test - Gonorrhoea - Product Status
Table 17: ESP-Based Diagnostic Test - Gonorrhoea - Product Description
Table 18: ESP-Based Diagnostic Test - Group A Streptococci - Product Status
Table 19: ESP-Based Diagnostic Test - Group A Streptococci - Product Description
Table 20: ESP-Based Diagnostic Test - Malaria - Product Status
Table 21: ESP-Based Diagnostic Test - Malaria - Product Description
Table 22: ESP-Based Diagnostic Test - Pregnancy - Product Status
Table 23: ESP-Based Diagnostic Test - Pregnancy - Product Description
Table 24: Point of Care Flu-COVID Combination Diagnostic Test - Product Status
Table 25: Point of Care Flu-COVID Combination Diagnostic Test - Product Description
Table 26: Smart Phone Enabled Device - Product Status
Table 27: Smart Phone Enabled Device - Product Description
Table 28: Ellume Ltd, Key Employees
Table 29: Glossary
List of Figures
Figure 1: Ellume Ltd Pipeline Products by Equipment Type
Figure 2: Ellume Ltd Pipeline Products by Development Stage

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us